Abbott wraps up $310M buyout of IDEV Technologies

08/26/2013 | MassDevice.com (Boston)

Abbott has completed its purchase of IDEV Technologies for $310 million. The acquisition includes IDEV's Supera Veritas system, a self-expanding stent designed to treat patients with peripheral artery disease. The device already is available commercially in Europe, but is still undergoing FDA premarket review.

View Full Article in:

MassDevice.com (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX